ALXO
#3420
ALX Oncology Holdings Inc. - Common Stock
2.0 4 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.00%
Variación mensual
+28.30%
Variación en los últimos 6 meses
+67.21%
Cambio anual
+334.04%
Cierres anteriores
2.0 0
Open
2.0 1
Mínimo
2.0 1
High
2.0 6
Volumen
208
Financials
- Market Capitalization 274.51 M
- Employee 43
- Founded 2015
- CEO N/A
- Website www.alxoncology.com
- Headquarter Delaware, United States
- FIGI BBG00VR8SDG8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3405 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.62 USD | +0.56% | -3.98% | -7.18% | +29.29% | 276.80 M USD | ||
| 3411 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | 0.00% | +23.95% | +15.00% | 273.31 M USD | ||
| 3422 |  MGNX MacroGenics, Inc. - Common Stock | 4.33 USD | +0.93% | -7.08% | +4.34% | +188.67% | 275.23 M USD | ||
| 3427 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.11 USD | +4.56% | -2.87% | +8.88% | +2.01% | 276.01 M USD |